Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de William Doyle
Age : 58
Public asset : 44,554,425 USD
Country of residence : Unknown
Linked companies : Elanco Animal Health Incorporated - NovoCure Limited - Minerva Neurosciences, Inc.

Biography of William Doyle 
Mr. William F. Doyle is an Independent Director at Elanco Animal Health, Inc., a Lead Independent Director at Minerva Neurosciences, Inc., an Executive Chairman at NovoCure Ltd., a Co-Founder & Managing Director at WFD Ventures LLC and an Executive Chairman at Blink Health, Inc. He is on the Board of Directors at Elanco Animal Health, Inc., Minerva Neurosciences, Inc., OptiNose US, Inc., Aspire Bariatrics, Inc. and VisionScope Technologies LLC. Mr. Doyle was previously employed as an Independent Director by Zoetis, Inc., a Member-Investment Team by Pershing Square Capital Management LP, an Independent Director by OptiNose, Inc., a Non-Executive Director by Advanced Surgical Concepts Ltd., a Principal by American Superconductor Corp., a President by Biosense Webster, Inc., an Advisor by Cutlass Capital LLC, a Founder by Durel Corp, a Chairman by ImaCor, Inc., a Managing Director by Insight Venture Management LLC, a Vice President-Licensing & Acquisitions by Johnson & Johnson, and a Consultant by McKinsey & Co., Inc. He also served on the board at OptiNose AS, Revitas, Inc., Andrew Technologies LLC, Angioslide Ltd., BionX Medical Technologies, Inc., Clozex Medical LLC, Cordis Corp., Inventure LLC, Johnson & Johnson Innovation JJDC, Inc., Medusind of Miami, Inc., NanoPass Technologies Ltd., ProterixBio, Inc. and Vision-Sciences, Inc. He received his undergraduate degree from Massachusetts Institute of Technology and an MBA from Harvard Business School.


Current positions of William Doyle 
Holdings of William Doyle 
William Doyle : Personal Network 
Most Read News 
06/22ELON MUSK : Musk says Tesla's new car factories 'losing billions of dollars'
RE
06/28WARREN BUFFETT : Buffett's Berkshire buys more Occidental shares, raises stake to about 16.4%
RE
07/02ELON MUSK : Musk breaks silence on Twitter, posts a picture with the pope
RE
06/29MUKESH AMBANI : Factbox-Ambani children at centre of leadership change at India's Reliance
RE
06/23MARK MILLER : Column-Want to do something about your ailing retirement savings? Don't
RE
06/28RALPH HAMERS : UBS head of strategy to depart bank for entrepreneurship
RE
06/22TREVOR MILTON : Nikola founder Trevor Milton faces new fraud charge
RE
06/22RUPERT MURDOCH : Rupert Murdoch and Jerry Hall are getting a divorce - NYT
RE
06/21ELON MUSK : Musk says there are still a few unresolved matters with Twitter deal
RE
06/23MASAYOSHI SON : Nasdaq listing most likely for Arm - SoftBank's Son
RE
More news


© 2022 People and Ownership :   
William Doyle : Connections 


Latest news about William Doyle 
04/28TRANSCRIPT : NovoCure Limited, Q1 2022 Earnings Call, Apr 28, 2022
CI
02/24TRANSCRIPT : NovoCure Limited, Q4 2021 Earnings Call, Feb 24, 2022
CI
01/11TRANSCRIPT : NovoCure Limited Presents at JPMorgan 40th Annual Healthcare Conference, Jan-11-2022 07:30 AM
CI
2021TRANSCRIPT : NovoCure Limited Presents at Piper Sandler 33rd Annual Virtual Healthcare Conference, Nov-30-2021 01:00 PM
CI
2021TRANSCRIPT : NovoCure Limited, Q3 2021 Earnings Call, Oct 28, 2021
CI
2021TRANSCRIPT : NovoCure Limited, Q2 2021 Earnings Call, Jul 29, 2021
CI
2021TRANSCRIPT : Minerva Neurosciences, Inc. - Shareholder/Analyst Call
CI
More news